FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2092375805> ?p ?o ?g. }

• W2092375805 endingPage "827" @default.
• W2092375805 startingPage "813" @default.
• W2092375805 abstract "Background. Intravenous immunoglobulin (IGIV) is used in the treatment of a wide variety of immune disorders. To our knowledge, no comprehensive or systematic review on the pharmacokinetics of IGIV has been published despite the availability of many published individual studies. Objective. To systematically review published studies of the pharmacokinetics of IGIV Methodology. We conducted a search of PubMed/MEDLINE from January 1966–September 2005 and EMBASE from January 1980–September 2005 for English-language articles on the pharmacokinetics of IGIV. This search was supplemented by a bibliographic review of all relevant articles. Results. Data elements extracted from these articles included study design, number of study subjects, indication for IGIV therapy, IGIV treatment regimen (formulation, dosage, and duration), pharmacokinetic parameters (clearance, volume of distribution, elimination rate constant, and half-life), analytic methodology, pharmacokinetic model, and blood sampling times. The United States Preventive Services Task Force rating scale was used to categorize the 50 pertinent citations identified in our literature search. According to the rating scale, 12 studies were level I (prospective, randomized, controlled studies), 3 were level II-1 (prospective, nonrandomized, controlled studies), 30 were level II-2 (prospective, nonrandomized, uncontrolled [cohort] studies), and 5 were level III (case reports or descriptive studies). Conclusion. The pharmacokinetics of IGIV shows considerable intra- and interpopulation variability among patients with normal immunoglobulin levels, patients with primary immunodeficiency diseases, bone marrow transplant recipients, patients with immune deficiency due to chronic lymphocytic leukemia or multiple myeloma, very low birth weight neonates, neonates with suspected sepsis, high-risk infants in the neonatal intensive care unit, high-risk infants with cardiopulmonary disease, children with cryptogenic West or Lennox-Gastaut syndrome, women and infants with fetal alloimmune thrombocytopenia, and women with recurrent spontaneous abortions. Despite the large number of studies characterizing the pharmacokinetics of IGIV, major literature gaps include lack of information on IGIV clearance or area under the curve parameters and target serum immunoglobulin G concentrations. Further study is needed to rigorously characterize the pharmacokinetic properties of IGIV in a range of patient populations." @default.
• W2092375805 created "2016-06-24" @default.
• W2092375805 creator A5011941324 @default.
• W2092375805 creator A5073337287 @default.
• W2092375805 date "2006-06-01" @default.
• W2092375805 modified "2023-10-17" @default.
• W2092375805 title "Pharmacokinetics of Intravenous Immunoglobulin: A Systematic Review" @default.
• W2092375805 cites W121740414 @default.
• W2092375805 cites W184447267 @default.
• W2092375805 cites W1967163855 @default.
• W2092375805 cites W1968300672 @default.
• W2092375805 cites W1971685309 @default.
• W2092375805 cites W1974743489 @default.
• W2092375805 cites W1976002362 @default.
• W2092375805 cites W1978946546 @default.
• W2092375805 cites W1982149578 @default.
• W2092375805 cites W1985452681 @default.
• W2092375805 cites W1995086660 @default.
• W2092375805 cites W1995675505 @default.
• W2092375805 cites W1995927618 @default.
• W2092375805 cites W2000948356 @default.
• W2092375805 cites W2001592943 @default.
• W2092375805 cites W2001905490 @default.
• W2092375805 cites W2002401872 @default.
• W2092375805 cites W2002992168 @default.
• W2092375805 cites W2007406369 @default.
• W2092375805 cites W2014975540 @default.
• W2092375805 cites W2015488597 @default.
• W2092375805 cites W2016001191 @default.
• W2092375805 cites W2016132554 @default.
• W2092375805 cites W2016694138 @default.
• W2092375805 cites W2019422498 @default.
• W2092375805 cites W2019882043 @default.
• W2092375805 cites W2029950889 @default.
• W2092375805 cites W2032875236 @default.
• W2092375805 cites W2033973075 @default.
• W2092375805 cites W2036747476 @default.
• W2092375805 cites W2048099106 @default.
• W2092375805 cites W2050200780 @default.
• W2092375805 cites W2050900492 @default.
• W2092375805 cites W2056538420 @default.
• W2092375805 cites W2062826169 @default.
• W2092375805 cites W2066119033 @default.
• W2092375805 cites W2070498696 @default.
• W2092375805 cites W2077377992 @default.
• W2092375805 cites W2080073611 @default.
• W2092375805 cites W2091352495 @default.
• W2092375805 cites W2101586643 @default.
• W2092375805 cites W2121435005 @default.
• W2092375805 cites W2129320828 @default.
• W2092375805 cites W2153202624 @default.
• W2092375805 cites W2287213343 @default.
• W2092375805 cites W2326827756 @default.
• W2092375805 cites W4238467333 @default.
• W2092375805 cites W4301669883 @default.
• W2092375805 doi "https://doi.org/10.1592/phco.26.6.813" @default.
• W2092375805 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16716135" @default.
• W2092375805 hasPublicationYear "2006" @default.
• W2092375805 type Work @default.
• W2092375805 sameAs 2092375805 @default.
• W2092375805 citedByCount "102" @default.
• W2092375805 countsByYear W20923758052012 @default.
• W2092375805 countsByYear W20923758052013 @default.
• W2092375805 countsByYear W20923758052014 @default.
• W2092375805 countsByYear W20923758052015 @default.
• W2092375805 countsByYear W20923758052016 @default.
• W2092375805 countsByYear W20923758052017 @default.
• W2092375805 countsByYear W20923758052018 @default.
• W2092375805 countsByYear W20923758052019 @default.
• W2092375805 countsByYear W20923758052020 @default.
• W2092375805 countsByYear W20923758052021 @default.
• W2092375805 countsByYear W20923758052022 @default.
• W2092375805 countsByYear W20923758052023 @default.
• W2092375805 crossrefType "journal-article" @default.
• W2092375805 hasAuthorship W2092375805A5011941324 @default.
• W2092375805 hasAuthorship W2092375805A5073337287 @default.
• W2092375805 hasBestOaLocation W20923758051 @default.
• W2092375805 hasConcept C112705442 @default.
• W2092375805 hasConcept C126322002 @default.
• W2092375805 hasConcept C17744445 @default.
• W2092375805 hasConcept C177713679 @default.
• W2092375805 hasConcept C187212893 @default.
• W2092375805 hasConcept C188816634 @default.
• W2092375805 hasConcept C199539241 @default.
• W2092375805 hasConcept C2779473830 @default.
• W2092375805 hasConcept C2781413609 @default.
• W2092375805 hasConcept C71924100 @default.
• W2092375805 hasConceptScore W2092375805C112705442 @default.
• W2092375805 hasConceptScore W2092375805C126322002 @default.
• W2092375805 hasConceptScore W2092375805C17744445 @default.
• W2092375805 hasConceptScore W2092375805C177713679 @default.
• W2092375805 hasConceptScore W2092375805C187212893 @default.
• W2092375805 hasConceptScore W2092375805C188816634 @default.
• W2092375805 hasConceptScore W2092375805C199539241 @default.
• W2092375805 hasConceptScore W2092375805C2779473830 @default.
• W2092375805 hasConceptScore W2092375805C2781413609 @default.
• W2092375805 hasConceptScore W2092375805C71924100 @default.
• W2092375805 hasIssue "6" @default.

• next